Family · Pharmaceutical analytical standards
Olsalazine
An intestinal anti-inflammatory made of two mesalazine molecules joined by an azo bond, approved in the United States in 1990 to maintain remission of ulcerative colitis. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?It reaches the colon intact: there the gut bacteria, with their azoreductase enzymes, break the bond and release mesalazine exactly where it is needed.
No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
